These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 25802203)
1. Lack of evidence that adherence to standard of care therapy improves survival in subjects with hepatocellular carcinoma in clinical practice. Guarino M; Stroffolini T; Lombardo FL; Loperto I; Auriemma F; Gentile I; Caporaso N; Morisco F J Med Virol; 2015 Aug; 87(8):1368-76. PubMed ID: 25802203 [TBL] [Abstract][Full Text] [Related]
2. Treatment of hepatocellular carcinoma in a tertiary Romanian center. Deviations from BCLC recommendations and influence on survival rate. Radu P; Groza I; Iancu C; Al Hajjar N; Andreica V; Sparchez Z J Gastrointestin Liver Dis; 2013 Sep; 22(3):291-7. PubMed ID: 24078986 [TBL] [Abstract][Full Text] [Related]
3. Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania. Guarino M; Tortora R; de Stefano G; Coppola C; Morisco F; Salomone Megna A; Izzo F; Nardone G; Piai G; Adinolfi LE; D'Adamo G; Gaeta GB; Messina V; Francica G; De Girolamo V; Coppola N; Persico M; Di Costanzo GG; J Gastroenterol Hepatol; 2018 May; 33(5):1123-1130. PubMed ID: 28994145 [TBL] [Abstract][Full Text] [Related]
4. Multimodality treatment of hepatocellular carcinoma: How field practice complies with international recommendations. Sangiovanni A; Triolo M; Iavarone M; Forzenigo LV; Nicolini A; Rossi G; La Mura V; Colombo M; Lampertico P Liver Int; 2018 Sep; 38(9):1624-1634. PubMed ID: 29791968 [TBL] [Abstract][Full Text] [Related]
5. Adherence to American Association for the Study of Liver Diseases guidelines for the management of hepatocellular carcinoma: results of an Italian field practice multicenter study. Borzio M; Fornari F; De Sio I; Andriulli A; Terracciano F; Parisi G; Francica G; Salvagnini M; Marignani M; Salmi A; Farinati F; Carella A; Pedicino C; Dionigi E; Fanigliulo L; Cazzaniga M; Ginanni B; Sacco R; Future Oncol; 2013 Feb; 9(2):283-94. PubMed ID: 23414477 [TBL] [Abstract][Full Text] [Related]
6. BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. Farinati F; Vanin V; Giacomin A; Pozzan C; Cillo U; Vitale A; Di Nolfo AM; Del Poggio P; Benvegnu' L; Rapaccini G; Zoli M; Borzio F; Giannini EG; Caturelli E; Trevisani F; Liver Int; 2015 Jan; 35(1):223-31. PubMed ID: 25074434 [TBL] [Abstract][Full Text] [Related]
7. Prognosis of untreated hepatocellular carcinoma. Giannini EG; Farinati F; Ciccarese F; Pecorelli A; Rapaccini GL; Di Marco M; Benvegnù L; Caturelli E; Zoli M; Borzio F; Chiaramonte M; Trevisani F; Hepatology; 2015 Jan; 61(1):184-90. PubMed ID: 25234419 [TBL] [Abstract][Full Text] [Related]
8. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma. Zhong JH; Ke Y; Gong WF; Xiang BD; Ma L; Ye XP; Peng T; Xie GS; Li LQ Ann Surg; 2014 Aug; 260(2):329-40. PubMed ID: 24096763 [TBL] [Abstract][Full Text] [Related]
9. Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study. Vitale A; Burra P; Frigo AC; Trevisani F; Farinati F; Spolverato G; Volk M; Giannini EG; Ciccarese F; Piscaglia F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Cabibbo G; Felder M; Gasbarrini A; Sacco R; Foschi FG; Missale G; Morisco F; Svegliati Baroni G; Virdone R; Cillo U; J Hepatol; 2015 Mar; 62(3):617-24. PubMed ID: 25450706 [TBL] [Abstract][Full Text] [Related]
10. External validation of a simplified BCLC staging system for early hepatocellular carcinoma. Santambrogio R; Salceda J; Costa M; Kluger MD; Barabino M; Laurent A; Opocher E; Azoulay D; Cherqui D Eur J Surg Oncol; 2013 Aug; 39(8):850-7. PubMed ID: 23726257 [TBL] [Abstract][Full Text] [Related]
12. Aggressive therapeutic strategies improve the survival of hepatocellular carcinoma patients with performance status 1 or 2: a propensity score analysis. Hsu CY; Liu PH; Lee YH; Hsia CY; Huang YH; Chiou YY; Tsai YJ; Nagaria TS; Huo TI Ann Surg Oncol; 2015 Apr; 22(4):1324-31. PubMed ID: 25326394 [TBL] [Abstract][Full Text] [Related]
13. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry. Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276 [TBL] [Abstract][Full Text] [Related]
14. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma. Heng-jun G; Yao-jun Z; Min-shan C; Mei-xian C; Jun-ting H; Li X; Lau WY Liver Int; 2014 Apr; 34(4):612-20. PubMed ID: 24028297 [TBL] [Abstract][Full Text] [Related]
15. Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis. Torzilli G; Donadon M; Marconi M; Palmisano A; Del Fabbro D; Spinelli A; Botea F; Montorsi M Arch Surg; 2008 Nov; 143(11):1082-90. PubMed ID: 19015467 [TBL] [Abstract][Full Text] [Related]
16. Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: Modern surgical resection as a feasible alternative to transarterial chemoemolization. Ciria R; López-Cillero P; Gallardo AB; Cabrera J; Pleguezuelo M; Ayllón MD; Luque A; Zurera L; Espejo JJ; Rodríguez-Perálvarez M; Montero JL; de la Mata M; Briceño J Eur J Surg Oncol; 2015 Sep; 41(9):1153-61. PubMed ID: 26118317 [TBL] [Abstract][Full Text] [Related]
17. Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study. Vitale A; Morales RR; Zanus G; Farinati F; Burra P; Angeli P; Frigo AC; Del Poggio P; Rapaccini G; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Giannini EG; Caturelli E; Chiaramonte M; Trevisani F; Cillo U; Lancet Oncol; 2011 Jul; 12(7):654-62. PubMed ID: 21684210 [TBL] [Abstract][Full Text] [Related]
18. Adherence to Barcelona Clinic Liver Cancer therapeutic algorithm for hepatocellular carcinoma in the daily practice: a multicenter cohort study from Argentina. Piñero F; Marciano S; Fernández N; Silva J; Zambelo Y; Cobos M; Zerega A; Ridruejo E; Miguez C; Ameigeiras B; D'Amico C; Gaite L; Coronel M; Bermúdez C; Rosales C; Romero G; McCormack L; Reggiardo V; Colombato L; Gadano A; Rubinstein F; Silva M; Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):376-383. PubMed ID: 29509603 [TBL] [Abstract][Full Text] [Related]
19. Barcelona Clinic Liver Cancer staging system and survival of untreated hepatocellular carcinoma in a hepatitis B virus endemic area. Lee JH; Kim HY; Kim YJ; Yoon JH; Chung JW; Lee HS J Gastroenterol Hepatol; 2015 Apr; 30(4):696-705. PubMed ID: 25250761 [TBL] [Abstract][Full Text] [Related]
20. Comparison of survival of patients with BCLC stage A hepatocellular carcinoma after hepatic resection or transarterial chemoembolization: a propensity score-based analysis. Guo Z; Zhong JH; Jiang JH; Zhang J; Xiang BD; Li LQ Ann Surg Oncol; 2014 Sep; 21(9):3069-76. PubMed ID: 24728740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]